What is Amylyx Pharmaceuticals, Inc.'s gross profit?

Amylyx Pharmaceuticals, Inc. (AMLX) reported gross profit of $0 in Q4 2025.

What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s gross profit?

Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s gross profit has grown at a -100.0% compound annual growth rate (CAGR), from $355.35M to $0.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.

Amylyx Pharmaceuticals, Inc. AMLX Gross Profit

Discontinued — last reported Q4 '25

Gross Profit at other companies

Crinetics PharmaceuticalsCRNX

$10.53M+2,818%

Agios PharmaceuticalsAGIO

$19.43M+154%

Rhythm Pharmaceuticals, Inc.RYTM

$52.96M+82.3%

uniQureQURE

$3.34M+144%

BioCryst PharmaceuticalsBCRX

$151.04M+7.1%

Acadia PharmaceuticalsACAD

$243.27M+8.6%

Other financials

Income statement

See full

Revenue-—

Operating income-$43.8M-15.8%

Net income-$41.3M-15.0%

EPS (diluted)-$0.37+11.9%

Balance sheet

See full

Cash & equivalents$229.1M+283%

Total debt$5.6M+307%

Total equity$273.2M+35.6%

Total assets$293.6M+33.7%

Cash flow

See full

Operating cash flow-$36.9M+7.4%

CapEx$86.0K+330%

Free cash flow-$28.0M+52.6%

Valuation

See full

Market cap$1.82B+390%

Enterprise value$1.6B+414%

Profitability

See full

Gross margin100%+6.9pp

Operating margin-47,349.8%-47,409pp

Net margin-45,096.2%-45,152pp

FCF margin-39,826.7%-39,847pp

Returns & leverage

See full

Return on equity-63.3%-12.2pp

Debt / equity0×0.0×

Current ratio17.9×+5.8×

Where this comes from

Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.

-total revenue−-total cost of revenue=$0

The official record: Amylyx Pharmaceuticals, Inc.’s 10-K, filed March 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s gross profit?: Amylyx Pharmaceuticals, Inc. (AMLX) reported gross profit of $0 in Q4 2025.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s gross profit?: Over 2 years (2023 to 2025), Amylyx Pharmaceuticals, Inc.'s gross profit has grown at a -100.0% compound annual growth rate (CAGR), from $355.35M to $0.
What does gross profit mean?: Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.